The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Funders
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Funders
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
eJHaem
(Dec 2024)
Metabolic pitfall of pseudoprogression after epcoritamab treatment
Osamu Imataki,
Shumpei Uchida,
Makiko Uemura
Affiliations
Osamu Imataki
Department of Internal Medicine, Division of Hematology Kagawa University Hospital Miki Japan
Shumpei Uchida
Department of Internal Medicine, Division of Hematology Kagawa University Hospital Miki Japan
Makiko Uemura
Department of Internal Medicine, Division of Hematology Kagawa University Hospital Miki Japan
DOI
https://doi.org/10.1002/jha2.1026
Journal volume & issue
Vol. 5, no. 6
pp. 1346 – 1347
Abstract
Read online
No abstracts available.
Keywords
18F‐FDG‐PET
epcoritamab
malignant lymphoma
pseudoprogression
WeChat QR code
Close
